Fig. 1 Construction and differentiation process of vascular organoids.
Product Details
Product Details
Product Specification
| Endotoxin | <0.1EU/μg |
| Physical Appearance | Lyophilized powder |
| Reconstitution | Reconstitute at 0.1-1mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage |
·12 months from date of receipt,lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterileconditions after reconstitution. · 1 week, 2 to 8℃ under sterileconditions after reconstitution. · Please avoidrepeated freeze-thaw cycles. |
Components
| Protein | 100ml System | 1000ml System |
| BMP-4 Protein, Human | 5μg | 50μg |
| VEGF-121 Protein, Human | 10μg | 100μg |
| FGF-basic(154aa) Protein, Human | 10μg | 100μg |
Guidelines
Avoid vortex oscillation; Store in portions to reduce the number of freeze-thaw cycles
Picture
Picture
Bioactivity


Fig.
2 Immunofluorescence detection of characteristic protein expression in vascular
organoids: the vascular organoids express endothelial cell marker CD31 (green)
and pericyte marker SMA (red)

Fig.
3 Immunohistochemical identification: the vascular organoids express
endothelial cell marker CLDN5 (brown).
